MapLight Therapeutics, Inc.
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
| Total revenue |
0.00 |
|
|
|
| Cost of revenue |
0.00 |
0.00 |
0.00 |
0.00 |
| Gross profit |
0.00 |
0.00 |
0.00 |
0.00 |
| Selling, general and administrative |
0.03 |
0.01 |
0.01 |
0.00 |
| Research and development |
0.14 |
0.07 |
0.05 |
0.03 |
| Other operating expenses |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating income |
-0.17 |
-0.08 |
-0.06 |
-0.03 |
| Non-operating income (net) |
0.01 |
0.01 |
0.00 |
0.00 |
| Income before tax |
-0.16 |
-0.08 |
-0.06 |
-0.03 |
| Net income |
-0.16 |
-0.08 |
-0.06 |
-0.03 |
Show Quarterly Income Statement
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Mar-23 |
| Total revenue |
0.00 |
0.00 |
0.00 |
|
|
0.00 |
0.00 |
|
|
|
| Cost of revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
0.00 |
0.00 |
0.00 |
| Gross profit |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
0.00 |
0.00 |
0.00 |
| Selling, general and administrative |
0.01 |
0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Research and development |
0.05 |
0.06 |
0.03 |
0.03 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
| Other operating expenses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating income |
-0.06 |
-0.08 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
| Non-operating income (net) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.06 |
-0.08 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
| Net income |
-0.06 |
-0.08 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
| Cash and cash equivalents |
0.05 |
0.04 |
0.08 |
0.03 |
| Short-term investments |
0.26 |
0.07 |
|
|
| Other current assets |
0.02 |
0.01 |
0.00 |
0.00 |
| Total current assets |
0.32 |
0.11 |
0.08 |
0.03 |
| Property, plant and equipment, net |
|
|
|
|
| Goodwill |
|
|
|
|
| Intangible assets |
|
|
|
|
| Long-term investments |
0.15 |
|
|
|
| Other non-current assets |
|
|
|
|
| Total assets |
0.48 |
0.14 |
0.09 |
0.04 |
|
| Accounts payable |
0.00 |
0.00 |
0.00 |
0.00 |
| Short-term debt |
0.00 |
0.00 |
0.00 |
0.00 |
| Current portion of long-term debt |
|
|
|
|
| Deferred revenue |
|
|
|
|
| Other current liabilities |
0.02 |
0.01 |
0.01 |
0.00 |
| Long-term debt |
|
|
|
|
| Capital lease obligations |
0.01 |
|
|
|
| Other non-current liabilities |
|
|
|
|
| Total liabilities |
0.02 |
0.02 |
0.02 |
0.02 |
|
| Common stock and paid-in capital |
0.82 |
0.31 |
0.19 |
0.09 |
| Retained earnings |
-0.36 |
-0.20 |
-0.12 |
-0.07 |
| Common shares outstanding |
44 |
41 |
41 |
41 |
Show Quarterly Balance Sheet
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Mar-23 |
| Cash and cash equivalents |
0.06 |
0.05 |
0.06 |
0.03 |
0.05 |
0.04 |
|
|
0.18 |
|
| Short-term investments |
0.25 |
0.26 |
0.16 |
0.03 |
0.04 |
0.07 |
|
|
|
|
| Other current assets |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
|
|
0.00 |
-0.03 |
| Total current assets |
0.33 |
0.32 |
0.25 |
0.07 |
0.10 |
0.11 |
|
|
0.18 |
|
| Property, plant and equipment, net |
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
|
|
| Long-term investments |
0.09 |
0.15 |
0.00 |
|
|
0.01 |
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
|
|
| Total assets |
0.42 |
0.48 |
0.26 |
0.08 |
0.11 |
0.14 |
|
|
0.19 |
|
|
| Accounts payable |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
0.00 |
|
| Short-term debt |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
0.00 |
|
| Current portion of long-term debt |
|
|
|
|
|
|
|
|
|
|
| Deferred revenue |
|
|
|
|
|
|
|
|
|
|
| Other current liabilities |
0.01 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
|
|
0.01 |
|
| Long-term debt |
|
|
|
|
|
|
|
|
|
|
| Capital lease obligations |
0.01 |
0.01 |
0.01 |
|
|
0.01 |
|
|
|
|
| Other non-current liabilities |
|
|
|
|
|
|
|
|
|
|
| Total liabilities |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.33 |
|
|
0.02 |
-0.02 |
|
| Common stock and paid-in capital |
0.82 |
0.82 |
0.51 |
0.32 |
0.31 |
0.31 |
0.00 |
0.00 |
0.31 |
0.02 |
| Retained earnings |
-0.42 |
-0.36 |
-0.28 |
-0.25 |
-0.22 |
-0.20 |
|
|
-0.14 |
|
| Common shares outstanding |
45 |
44 |
41 |
41 |
41 |
41 |
41 |
41 |
41 |
41 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
| Net income |
|
|
|
|
| Depreciation, depletion and amortization |
0.00 |
0.00 |
0.00 |
0.00 |
| Stock-based compensation |
0.04 |
|
|
|
| Change in inventory |
|
|
|
|
| Other working capital changes |
-0.17 |
-0.08 |
-0.05 |
-0.03 |
| Capital expenditures |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
-0.32 |
-0.08 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
| Common stock repurchases |
|
|
|
|
| Net Debt Issuance |
0.47 |
0.12 |
0.10 |
0.03 |
|
| Change in cash |
0.01 |
-0.04 |
0.05 |
0.01 |
Show Quarterly Cash Flow
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Mar-23 |
| Net income |
|
|
|
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Stock-based compensation |
0.01 |
0.04 |
0.00 |
|
|
0.00 |
0.00 |
|
|
|
| Change in inventory |
|
|
|
|
|
|
|
|
|
|
| Other working capital changes |
-0.06 |
-0.08 |
-0.03 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
| Capital expenditures |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
0.07 |
-0.24 |
-0.14 |
0.02 |
0.04 |
0.03 |
0.01 |
-0.12 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
|
|
|
|
|
|
| Common stock repurchases |
|
|
|
|
|
|
|
|
|
|
| Net Debt Issuance |
-0.01 |
0.27 |
0.20 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.12 |
0.00 |
|
| Change in cash |
0.01 |
-0.02 |
0.03 |
-0.02 |
0.01 |
0.01 |
-0.01 |
-0.14 |
0.10 |
-0.01 |
MapLight Therapeutics, Inc. (MPLT) - Other Current Liabilities
MapLight Therapeutics, Inc. (MPLT) - Short Long Term Debt Total
MapLight Therapeutics, Inc. (MPLT) - Capital Lease Obligations
MapLight Therapeutics, Inc. (MPLT) - Total Non Current Liabilities
MapLight Therapeutics, Inc. (MPLT) - Short Term Debt
MapLight Therapeutics, Inc. (MPLT) - Current Accounts Payable
MapLight Therapeutics, Inc. (MPLT) - Total Current Liabilities
MapLight Therapeutics, Inc. (MPLT) - Total Liabilities
MapLight Therapeutics, Inc. (MPLT) - Other Current Assets
MapLight Therapeutics, Inc. (MPLT) - Short Term Investments